Company news
Avacta Group PLC news in 2016
Avacta Group PLC's news releases, calls and decks from 2016, newest first.
Notice of AGM, Accounts and Directorate Change
December 1, 2016
Technical Update: Affinity Separation
November 23, 2016
Cancer Expert joins Scientific Advisory Board
November 7, 2016
CAR-T Cell Therapy Research Collaboration in US
November 2, 2016
Results from first Affimer pre-clinical studies
November 1, 2016
Director's Dealing
October 21, 2016
Hardman Research: Great strides to strategic goals
October 17, 2016
Prelim Results for the Year Ended 31 July 2016
October 17, 2016
Positive results from first preclinical studies
September 22, 2016
Change of Adviser
September 12, 2016
Change of Registered Office
August 31, 2016
New Facilities in Cambridge and Wetherby
August 16, 2016
Grant Funding
August 10, 2016
Key Affimer patents to be granted in Europe and US
August 3, 2016
Trading Statement
August 1, 2016
Hardman report: New Affimer opportunities
July 19, 2016
Collaboration with Glythera
July 14, 2016
Affimer Binders for Zika Virus Diagnostics
June 22, 2016
Collaboration with Mologic
June 13, 2016
Half-year Report
April 25, 2016
Affimer Therapeutic Platform Development Milestone
April 19, 2016
Investor Evening
April 5, 2016
Avacta Establishes Scientific Advisory Board
March 7, 2016
Grant Funding Awarded
February 24, 2016
Hardman & Co Issues Research Report
February 23, 2016
Directors' Dealings and Issue of Equity
February 17, 2016
Share Consolidation
January 26, 2016
Pre-close trading update
January 25, 2016
Philippe Cotrel Appointed Chief Commercial Officer
January 25, 2016
Proposed Shareholder Consolidation
January 21, 2016
Posting of Annual Report & Accounts and AGM Notice
January 7, 2016
Decks in 2016
- H1 2016 Earnings Presentation
Earnings · 32 slides · Apr 25, 2016